Presentation at the 13th Annual EORTC PatoBiology Group Meeting on September 15, 2018 in Hamburg, Germany

CSO Jan Stenvang will present data on SCO-101 and endocrine  resistance in breast cancer at the 13th Annual EORTC PathoBiology Group Meeting, Hamburg, Germany, September 13-15, 2018. EORTC (European Organisation for Research and Treatment of Cancer) is an independent, non-profit cancer research organisation, with the mission to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients.

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union